References
- Yoon Y H, Cho W I, Seo S J. Case of multiple myeloma associated with extramedullary cutaneous plasmacytoma and pyoderma gangrenosum. Int J Dermatol 2006; 45: 594–597
- Fox L P, Geyer A S, Husain S, Grossman M E. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukaemia. Leuk Lymphoma 2006; 47: 147–150
- Su W P, Davis M D, Weenig R H, Powell F C, Perry H O. Pyoderma gangrenosum: clinopathological correlation and proposed diagnostic criteria. Int J Dermatol 2004; 43: 790–800
- Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998; 102: 1115–1123
- Goulden V, Bond L, Highet A S. Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria. Clin Exp Dermatol 1994; 19: 271–273
- Kois J M, Sexton F M, Lookingbill D P. Cutaneous manifestations of multiple myeloma. Arch Dermatol 1991; 127: 69–74
- Van Epps D E, William R C, Jr. Supression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med 1976; 144: 1227–1242
- Wollina U. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol 2002; 3: 149–158
- Jenne L, Sauter B, Thumann P, Hertl M, Schuler G. Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody). Br J Dermatol 2004; 150: 380–382
- Franks M E, Macpherson G R, Figg W D. Thalidomide. Lancet 2004; 363: 1802–1811
- Nasca M R, O'Toole E A, Palicharla P, West D P, Woodley D T. Thalidomide increases human keratinocyte migration and proliferation. J Invest Dermatol 1999; 113: 720–724
- Federman G L, Federman D G. Recalcitrant pyoderma gangrenosum treated with thalidomide. Mayo Clin Proc 2000; 75: 842–844
- Venencie P Y, Saurat J H. Pyoderma gangrenosum in a child. Treatment with thalidomide. Ann Pediatr (Paris) 1982; 29: 67–69, [Article in French]
- Rustin M H, Gilkes J J, Robinson T W. Pyoderma gangrenosum associated with Behcet's disease: treatment with thalidomide. J Am Acad Dermatol 1990; 23: 941–944